Can A Person Die From Prostate Cancer:

prostate cancer

Prostate Cancer is a development of cancer in the prostate gland in the male reproductive system. Prostate cancer is slow growing cancer and they spread quickly. The main disadvantage of prostate cancer is that it can spread to different body parts, basically the bones and lymph nodes.

At initial stages, there are no symptoms but with advancement of cancer, there is difficulty in urination, pain in pelvic, blood in the urine.

Death from Prostate Cancer: 

Prostate cancer is a serious disease but most men suffering from prostate cancer do not die from it.
Based on a study, more than 3.1 million men in the USA who have been diagnosed with prostate cancer at some point are still alive today.

Causes of Prostate Cancer: 

The causes of prostate cancer are not clear yet. On behalf of the researchers, prostate cancer begins when a few normal cells divide normally. These abnormal cells live when other cells die and thus accumulate to form a tumor. This tumor can grow and break off to spread nearby body parts.

There are few factors that increase the risk of prostate cancer:

  • Age: With increasing age the risk of prostate cancer also increases. 
  • Race: It is assumed that black men have high risk of cancer.
  • Family History: Prostate cancer also runs in some families. 
  • Gene Changes: In a small number of cases, several inherited gene changes (mutations) seem to raise prostate cancer risk. 
  • Obesity: Obesity can cause advanced disease making it difficult to treat.

Prostate Cancer Medication: 

There are several medications that suppress the testosterone level and thus referred to as hormone therapy and androgen deprivation therapy (ADT). Some medications are:

  • Darolutamide: This helps in the elimination of prostate cancer.
  • Apalutamide: This is used in the treatment of non-metastatic cancer.
  • LHRH Agonists: This is a reversible process that inhibits the signals to be sended to the testosterone production.
  • Abiraterone Acetate: Abiraterone Acetate 250 mg is used to treat corticosteroid for metastatic castration-resistant prostate cancer (mCRPC). This drug is sold under the brand name Zytiga by name Xbira 250 mg. 
This medication is taken orally and used in combination with Gonadotropin releasing hormone (GnRH). Abiraterone Acetate 250 mg tablets must be stored below 25 degree Celsius.

The price of Abiraterone Acetate tablets is very economical and is available at a registered pharmaceutical company and can be taken after consulting your healthcare team.

Side Effects of Abiraterone Acetate: 

There are few severe side effects, which are mentioned as follows
  • Tiredness
  • Low blood potassium
  • Joint pain
  • Adrenocortical insufficiency
  • Liver failure
  • High blood sugar.

          

Comments

Post a Comment

Popular posts from this blog

Buy Trodelvy sacituzumab govitecan-hziy in India

  Trodelvy Overview: Trodelvy is widely prescribed by Oncologists for the treatment of patients with HR+/HER2- Metastatic Breast Cancer, Metastatic Triple-Negative Breast Cancer (mTNBC), and Metastatic Urothelial Cancer (mUC). It is considered a promising treatment option for those who are not ideal candidates for some conventional therapies. Developed by Immunomedics, Trodelvy 180 mg and Trodelvy 200 mg are two available commercial strengths. Worldwide, Trodelvy is promoted and facilitated by Gilead Sciences. Trodelvy is first approved on 22 April 2020. It is given by intravenous (IV) infusion by a health specialist. The medication received its (European Medicines Agency) EMA approval in October 2021. Trodelvy 180 mg and 200 mg injections are yet to be approved in India. The cost of Trodelvy in India usually depends on international factors. Buy Trodelvy from a Reliable Source: Many suppliers who are not authorized to handle or supply life-saving medicines such as Trodelvy found to b
Read more

Trodelvy: All about the drug

Image
Indication and Usage The medicine Trodelvy is a Trop-2-directed antibody and topoisomerase inhibitor conjugate drug, which is used in the treatment of adults suffering from locally advanced or metastatic triple-negative breast (mTNBC) cancer, HR+/HER2- metastatic breast cancer, and locally advanced or metastatic urothelial cancer (mUC). It is used when it is not possible to remove cancer with surgery. Trodelvy  comes in the form of single-dose vials in 180 mg for intravenous infusion. Dosage Its dosage is based on body weight, and the recommended dosage is 10 mg/kg administered intravenously once weekly on the first day and eighth day of a repeating 21-day cycle. Administration First infusion: The drug is infused in the body for 3 hours, and during the infusion, the patient is observed for any adverse reaction caused by the infusion. After 30 minutes of infusion, observation should be done again to check for any post-infusion reaction. Subsequent Infusion: If the drug is tolerated in t
Read more

What is Non-Small Cell Lung Cancer? What are the stages of NSCLC?

Image
NSCLC, the most common form of lung cancer. It occurs when the healthy cells in the lung change and start growing in an abnormal way, forming a specific mass addressed as tumor, lesion, or nodule. A tumor may develop anywhere in the lung and could be cancerous or benign. A cancerous tumor mainly is malignant, means, it has potential in order to spread to the rest part of the body. A benign tumor is the tumor that can grow but can not spread.  Non-Small Cell Lung Cancer (NSCLC) occurs in the epithelial cells. Doctors can also describe this form of Cancer (NSCLC) based on the type of the epithelial cell where the cancer usually starts.  Adenocarcinoma starts in cells that produce mucus.  Squamous carcinoma basically developed in the cells that line the airways.  Large cell carcinoma usually begins in the cells other than the two types which are described above.  It’s necessary for healthcare providers to distinguish between lung cancer that begins in the squamous cells from lung cancer
Read more